Tag
The SWEDEGRAFT trial reveals no significant difference in 7-year major clinical outcomes between no-touch and conventional saphenous vein harvesting in CABG, despite prior reports of improved graft patency but increased leg wound complicati
This analysis of a randomized trial finds no survival benefit at 15 years for bilateral versus single internal thoracic artery grafting in coronary bypass surgery, highlighting the need for further trials to clarify the multiple arterial gr
Expedited discharge (≤4 days) following isolated coronary artery bypass grafting is linked to shorter hospital stays, lower costs, and reduced 30-day readmissions without increased mortality or major complications, supporting selective impl
In a large Medicare study, multiarterial grafting after CABG looked beneficial in standard analysis, but the advantage disappeared with instrumental variable adjustment, suggesting earlier observational studies may have overestimated surviv
This review synthesizes current evidence on the efficacy and safety of ticagrelor combined with aspirin compared to aspirin alone following CABG for acute coronary syndrome, highlighting the 2025 TACSI trial and its implications for clinica
A multicenter prospective study reveals a higher incidence but very low burden of new-onset atrial fibrillation post-CABG, challenging current anticoagulation guidelines.
The NEWTON-CABG CardioLink-5 trial found that intensive LDL-C lowering with evolocumab did not improve saphenous vein graft patency 24 months after coronary artery bypass surgery despite significant LDL-C reductions.
